Search

Your search keyword '"Pavord, I."' showing total 892 results

Search Constraints

Start Over You searched for: Author "Pavord, I." Remove constraint Author: "Pavord, I."
892 results on '"Pavord, I."'

Search Results

2. Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis

3. Efficacité du dupilumab chez des patients avec et sans réduction minimale importante de la fraction de monoxyde d’azote dans l’air expiré après 2 semaines

6. Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey

7. Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

9. Le traitement par mépolizumab permet d’atteindre la rémission clinique chez les patients atteints d’asthme sévère à éosinophiles : résultats de l’étude en vie réelle REDES

11. S78 Biologic therapy practices in severe asthma; outcomes from the UK severe asthma registry and survey of specialist opinion

14. Biomarkers associated with lung function decline and dupilumab response in patients with moderate-to-severe asthma

17. Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab

18. Randomised, double-blind, placebo-controlled study to assess long-term effect of dupilumab on prevention of lung function decline (LFD) in patients with uncontrolled moderate-to-severe asthma: ATLAS trial

19. Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study

22. Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)

24. Continuous associations of type 2 biomarkers and efficacy of dupilumab in children with uncontrolled, moderate-to-severe asthma

32. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

35. Effect of Dupilumab on Lung Function Parameters in Oral Corticosteroid-Dependent Patients With Asthma Enrolled in LIBERTY ASTHMA TRAVERSE

38. P59 Baseline characteristics and medical history of patients with refractory or unexplained chronic cough participating in two global phase 3 clinical trials

42. P60 Patient-reported improvements with gefapixant, a P2X3-receptor antagonist, over 52 weeks in two phase 3 clinical trials for refractory or unexplained chronic cough

43. The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD

44. Oral corticosteroid-dependent asthma

45. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

49. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

Catalog

Books, media, physical & digital resources